A case report describes severe nausea, vomiting and diarrhea one day after a patient resumed semaglutide following a five-week interruption [1]. For a single late dose, the guide to missed doses explains the instructions for specific products. Ask your prescriber how to resume treatment after a longer gap.
What happened
The patient had obesity, hypertension, high cholesterol and anxiety. She had been on semaglutide 2.4 mg for roughly a year, with good tolerance and successful weight loss. [1] The treatment was interrupted for five weeks during Ramadan.
She restarted at the dose she had been on. Within a day she had severe nausea, vomiting and diarrhea, and laboratory testing found significant electrolyte abnormalities. Severe gastrointestinal intolerance needing hospitalization is described in the literature as rare.
What the gap costs while it lasts
A model based on six studies with 1,776 participants estimated average regain of 1.04 kg per month after discontinuing semaglutide or tirzepatide [3]. The 95% credible interval runs 0.80 to 1.29, after an average loss of 15.35 kg. Observed follow-up ran from 4 to 52 weeks.
The analysis of weight regain after stopping describes an average across studies. It does not predict how much weight someone will regain during a five-week interruption.
The alternative to a full stop
The maintenance trial enrolled 441 participants. At week 60, it randomized 378 to continue their maximum tolerated dose of 10 or 15 mg, reduce to 5 mg, or switch to placebo [2]. Weight at week 112 sat 21.9% below baseline on the full dose, 16.6% at 5 mg, and 9.9% on placebo.
Under the trial protocol, rescue treatment began in 8% of the higher-dose group, 25% of the 5 mg group and 67% of the placebo group. The maintenance trial breakdown explains when participants qualified for rescue treatment. The trial compared maintenance regimens after initial weight loss.
Why this belongs on a price site
A late shipment or a lapse between prepaid plans can interrupt treatment. Use the term and prepay check to see what sellers disclose about the supply period and renewal. Confirm the next shipment date with the pharmacy if you are running low.
The review of refill gaps explains how researchers count treatment interruptions. Studies use refill windows of different lengths [4]. The same gap can count as continuous treatment in one study and an interruption in another.
Check the instructions for your product
The current U.S. prescribing information for Wegovy injection calls for restarting dose escalation at a lower dose after two or more consecutive missed doses. Confirm the instructions for your product and next dose with your prescriber.
Tell your prescriber how long the interruption lasted and what dose you last took. The Danish study of semaglutide maintenance doses recorded temporary pauses and permanent discontinuation separately. It did not compare restart schedules or establish which dose someone should resume.